Gland Pharma Limited (GLAND)
Outcome of Board Meeting
Q1FY27 results (unaudited):
Consolidated:
Revenue 18.0bn +20% y-y (15.1bn)
EBITDA 4.9bn +34% y-y (3.7bn)
EBITDA margin 27.4% (24.4%) +300 bps y-y
PAT 3.2bn +47% y-y (2.2bn)
FY26 results (audited):
Standalone:
Revenue 45.5bn +10% y-y (41.3bn approx from prior data)
EBITDA 17.7bn (derived from PBT + D&A + Finance costs - Other income, see notes)
PAT 13.0bn
Consolidated:
Revenue 64.3bn
PAT 14.3bn
Dividend: Not stated
Commentary: The company highlighted strong start to FY27 driven by CDMO strategy execution and robust B2B demand. Recent product launches and investments in technology and capacity expansions position the company for sustainable long-term growth.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GLAND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GLAND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Gland Pharma Limited
Important.
The summary above is generated automatically from Gland Pharma Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.